Macular Degeneration
CMS raises Medicare allowable reimbursement rate for Visudyne
Published in Managed Care Weekly Digest, April 12th, 2004
The rate moved from approximately $1,304 to $1,404, as part of the Medicare Prescription Drug, Improvement, and Modernization Act of 2003 - this rate was determined using the Average Selling Price for Visudyne in Q4 2003 +6%.
In December 2003 and January 2004, QLT and Novartis provided information to CMS requesting an exception to the Medicare Prescription Drug, Improvement, and Modernization Act of 2003 and an appropriate...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Managed Care Weekly Digest
More Articles from Managed Care Weekly Digest
- Disability
New program developed to bring disability knowledge to managed care industry - Regulatory Issues
Report finds problems with regulated premiums proposal in California - Employer-Sponsored Health Insurance
Older workers choose managed care, study finds - Healthcare Access
Report says 36 million Americans are medically underserved - Hypercholesterolemia
Outcome improvement program designed to lower LDL cholesterol levels - Allergy Medicine
New research on the treatment of anaphylaxis presented 2004 AAAAI meeting - More from this issue of Managed Care Weekly Digest
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
